The Relationship Between Thymus and Oncogenesis: A Study of the Incidence of Non Thymic Malignancy in Myasthenia Gravis by Papatestas, A. E. et al.
635
THE RELATIONSHIP BETWEEN THYMUS AND ONCOGENESIS
A STUDY OF THE INCIDENCE OF NON THYMIC MALIGNANCY
IN MYASTHENIA GRAVIS
A. E. PAPATESTAS, K. E. OSSERMAN AND A. E. KARK
Froin the Department ofSurgery, Medicine and the Myctsthenia Gravi8 Clinic and
Research Laboratory, The Mount Sinai Ho8pital, Mount Sinai School of Medicine
of the City Univer8ity of New York, New York, U.S.A.
Received for publ.ication June 29, 1971
SUMMARY.-The records of 1243 patients with myasthenia gravis (M.G.) have been reviewed in a retrospective study of the incidence of extrathymic
neoplasms. Ninety-four malignant neoplasms were traced.
The onset of the disease (M.G.) coincided with a marked increase in the
incidence of extrathymic neoplasms. The observed number of neoplasms
in the year of onset of M.G. was three times higher than the expected in a control
group. This was in sharp contrast to the lower than expected incidence in the
years preceding the onset of M.G.
The incidence remained at higher than the expected levels throughout the
course of the disease in patients who did not undergo thymectomy, while in
those patients who had thymectomy the incidence decreased to the levels of the
general population after the second postoperative year.
These observations suggest an oncogenic thymic influence. The possibility is discussed of the potential oncogenic role of abnormal clones of immuno-
competent small lymphocytes of thymic origin.
THE involvement of the thymus in the pathogenesis of malignant disease has
been suggested experimentally by alterations (increase or decrease) in the inci-
dence oftumor formation followingthymectomy (Miller, 1961), andby the clinical
observations that thymic pathology is often encountered in immunological disorders commonly associated withextrathymicneoplasms: primaryimmunologi- cal deficiency syndromes (Alexander and Good, 1970), autoimmune diseases
(Blumenthal and Berns, 1966; Pirofsky, 1968). These observations have led to
the suggestion that persistent thymic abnormalities might be associated with
diminished resistance to some types ofneoplasia (Miller, 1967).
Thymic pathology is frequently encountered in M.G. (Alpert et al., 1971), a
disease considered to be autoimmune in nature. To determine the role of the
thymus gland and the effects ofthymectomy on human oncogenesis, comparison has been made between the incidenceofextrathymicneoplasmsin non-thymectomy and in a thymectomy group of myasthenic patients.
Note: Requests for reprints should be addressed to: Dr. A. E. Kark, Department ofSurgery, The
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CLINICAL MATERIAL AND METHODS
The records of 1243 patients with myasthenia gravis who have been registered
at theMyasthenia Gravis Clinic ofthe Mount SinaiHospital (M.S.H.) ofNew York
City, New York, between the years 1951-71, have been reviewed.
The patients were separated into four categories according to the presence
or absence of thymomas, and whether or not they had undergone thymectomy
(Table I). The foUowing factors pertaining to the occurrence of neoplasia were
studied: the crude incidence ofmalignantneoplasms in each ofthe fourcategorieg,
the primary sites, the interval between the diagnosis and the onset of symptoms
TABLE L-1243 Patients with Myasthenia Gravis Followed at the, Mount
Sinai Hospital
No thymectomy Thymectomy All
A
r
Men Women Total Men Women Total Men Women Total
Myasthenia gravis
without thymoma 430 532 962 36 ill 147 466 643 1109
Thymomatous
myasthenia gravis 17* 38* 55* 32 47 79 49 85 134
447 570 1017 68 158 226 515 728 1243
Includes inoperable thymomas, those treated with irradiation and those diagnosed at autopsy.
TABLE II.-Per8on-Years of Observationfor the Three Periods at Ri8k
Period before onset Period after onset of M.G. Post-thymectomy of M.G. (non-thymectomy) period
A A A
Age groups Men Women Men Women Men Women
0-9 4814 6988 195 193 3 14
10-19 4620 6242 135 .491 17 112
20-29 4202 4636 198 1029 78 267
30-39 3564 3008 380 1236 40 243
40-49 2788 1806 470 1049 49 146
50-59 1950 886 577 660 22 37
60-69 806 392 470 287 21 22
70-79 130 148 211 114 8 4
80 over I 10 8 28
Total 22873 24116 2644 5085 238 845
of M.G. and the mortality due to these neoplasms. Adjustments for secular
time were not made since over 90% of the neoplasms occurred between 1951-70.
The risk of cancer development (extrathymic neoplasms) in these patients, based on person-years ofobservation, was assessed in the following threeperiods:
A. Before the onset ofM.G., i.e. from birth until the onset ofthe disease.
B. After the onset of the M.G. (M.G. non-thymectomy period), i.e. from the
time of onset of myasthenic symptoms until the time of thymectomy, death, loss to, or end offollow-up.
C. Post-thymectomy, i.e. from the time of operation until death, loss to, or
end offollow-up.
The person-years of observation in each category and for each period were
separated into 10 year age groups. The sex and age distribution of the person-
years ofobservation for the threeperiods are shown in Table II.637 THYMUS AND ONCOGENESIS
The observed numbers of extrathymic neoplasms in the M.G. patients were
compared with the expected numbers by applying the general population rates
(Cancerregistry ofConnecticut 1963) specific for sex and age, to the corresponding
sex and age groups of M.G. patients, and summing up the expected cases in each
category and for each period.
Two additional groups of Mount Sinai Hospital patients were used as control
populations: 760 patients admitted forherniorrhaphy (inguinal-femoral-umbilical)
in the period 1963-70 and 380 patients 'admitted for regional enteritis or granulo-
matous enterocolitis in the period 1955-70.
The risk of cancer development in these groups, based on person-years of
observation was assessedseparately fortheperiodpreceding andfollowing the year
of the hospital admission for hernia repair, or the year of admission in which the
diagnosis ofregional enteritis was first made. A separate assessment was made
for that year in both groups. Patients admitted for herniorrhaphy, in whom
TABLEIII.-Primary Site of 94 Extrathymic Neoplasln8in Patient8
with Mya8thenia GraVi8
Breast 25
Genital organs 14
Prostate (5), ovary (3), uterus (4), other (2)
Digestive organs 12
Colon-rectum (6), pancreas (2), liver (1)
stomach and small intestine (2), other (1)
Respiratory system 9
Lung (8), larynx (1)
Skin 7
Leukemia 6
Brain and CNS 5
Lymphomas 5
Lymphoma-lymphosarcoma 4
Multiple myeloma I
All other and unspecified
. II
All extrathymic sites 94
hernia repair was postponed because hospital workup revealed underlying neo-
plasia, were not excluded from the study. The sex and age distribution of the
person-years of observation were analyzed in a manner identical to that applied
to the M.G. population. The observed annual incidence of neoplasms for each
period at risk in the two groups was compared with thatexpected in a sex and age matched sample of the general population applying the same rates as in M.G.
patients.
Incidence ofmalignant neopla,89n8in M.G. patients
The total number of patients with associated malignancies, thymic or extra-
thymic was 126, of whom thirteen (10-5%) had multiple malignant neoplasms.
The total number of thymic and extrathymic malignant neoplasms was 140
(II% of all patients); forty-six were malignant thymomas and 94 extrathymic
tumors. (Eighty-eight additional thymomas classified clinically and pathologi- cally as benign were specifically not included in this study.) Histologic confirma-
tion ofmalignancy was av-ailable in 85 (90%) ofthe extrathymic neoplasms: in the
remainder the histology oftheneoplasms was indeterminate.638 A. E. PAPATESTAS. K. E. OSSERMAN AND A. E. KARK
Extrathymic malignancie,8
An overall incidence of 7-5% of extrathymic malignancies was noted; the
incidence was 7-4% for the non-thymomatous and 8-9% for the thymomatous
group.
The primary sites are shown in Table 111; 31 of these occurred in men and 63
in women. Breast was the most common primary site (40% of all neoplasms in
myasthenic women). Frequent occurrence of multiple extrathymic neoplasdis
was noted in myasthenic women who had notundergonethymectomy (8 patients).
The age ofdiagnosis ofthe extrathymicneoplasms is shown in Fig. I and com-
pared with the age ofonset ofM.G. in the 1243 patients. Fig. 2 shows the interval
between thediagnosis oftheneoplasms and the onset ofM.G.
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FiG. l.-Age distribution of onset of M.G. and ofextrathymic neoplasms in 1243 patients.
Based on the age and sex distribution of the 46, 989 person-years of observa-
tion for the periodpreceding the onset ofM.G. (Table 11), the expected number of
extrathymicneoplasms is 56; in fact 25 were observed. By contrast, the observed
number of neoplasms for M.G. non-thymectomy period (64) was considerably
higherthantheexpected (28). Fig. 3 shows thattheannualincidence ofneoplasms
increased sharply with the onset ofM.G. and remained high throughout the dura-
tion of the disease in patients who did not undergo thymectomy. Of the 64
neoplasms that occurred in the M.G. non-thymectomy period 39 were in women
and 25 in men; the expected figures are 14 and 14 respectively.
Following thymectomy, however, the annual incidence decreased to expected
levels (Fig. 4). Four of the five neoplasms that occurred in that period wereTHYMUS AND ONCOGENESIS 639
INTERVAL BETWEEN DIAGNOSIS OF EXTRATHYMIC MALIGNANT
NEOPLASMS AND ONSET OF M.G.
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diagnosed in the first two postoperative years. In the second five-year period
after thymectomy, the incidence ofneoplasms was not increased.
In the control group of hernia patients, the highest annual incidence of cancer
occurred in the yearfollowing admission for herniarepair. However, even in that
year the actual incidence was only slightly higher than the expected: (actual
5-26%0, expected 5-03%0) in contrast to the three-fold increase that occurred in-the
M.G. patients (Fig. 3). Furthermore, there was no sharp difference in the actual
incidence between theperiodbefore, and thatfollowing the year ofherniorrhaphy.
By contrast, in the second control group the incidence of neoplasms before the
onset of the regional enteritis and/or granulomatous enterocolitis was below the
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expected levels, while following the onset of the disease an increase to levels 50%
higherthan theexpectedoccurred. Comparison ofthe actual andexpected annual
incidence ofneoplasms for the yearfollowing the admission at which the diagnosis
of regional enteritis was made, did not reveal a sharp increase as in the M.G.
patients.
Mortality
Two hundred and seventy-five of the 1243 patients have died (22%). One
hunclred and seventy-eight deaths (64%) were directly due to M.G. (of which 101
occurredwithin 3 years ofthe onset ofM.G.) and 10ofthesefatalities hadassociated
extrathymic neoplasms. Twenty deaths were of undetermined cause and two
fatalities in this group had associatedextrathymicneoplasms.
Oftheremaining 77non-myasthenic deaths ofknown cause (28% ofalldeaths)641 THYMUS AND ONCOGENESIS
28 were directly attributed to extrathymic neoplasms; all the latter occurred in
patients who had not undergone thymectomy.
DISCUSSION
The effects of thymectomy in human oneogenesis have not been studied,
primarily because the operation, except for thymic tumours, has been essentially
limited to the treatment ofM.G., a rare disease in thegeneralpopulation(incidence:
I per 18,000) (Keynes, 1969).
The reported incidence of extrathymic neoplasms in patients with M.G.
varies between 1-4% and 2-5% and the association has until now been
considered to be fortuitous (Lambert and Rooke, 1965). Osserman (1958)
reported eight malignancies among 325 patients with myasthenia gravis (2-5%).
Lambert and Rooke (1965) reported 22 carcinomas in 857 patients with M.G.
seen at the Mayo Clinic (2-5%), while Wolf et al. (1966) found six neoplasms in
399 myasthenic patients (1-5%). Other scattered reports ofM.G. associated with
neoplasms have appeared since 1953 (Anderson et al., 1953; Cohen and Waxman,
1967).
Increased incidence ofextrathymic cancer inpatients withthymomaregardless
of the presence of M.G. has been reported by Souadjian et al. (1968). Of interest
is Ferguson's (1962) detailed follow-up study over 28 years of 145 cases of M.G.
A high mortality from extrathymic neoplasms is evident: 30 deaths occurred
i
patients who had not undergone thymectomy, 15 due to M.G. and 15 to non-
myasthenic causes; of the latter more than half (8) were due to malignant neo-
plasms (5 breast, I bronchus, I bladder, 1 gastrointestinal tract). No death was
attributed to neoplasia in thethymectomy group.
The frequency of breast cancer is noteworthy. In our series a high incidence
was observed in all three risk periods. A separate study on the relationship of
breast cancer and thymic abnormalities is to be reported.
The overall incidence ofmultiple neoplasms in M.G. patients (10-5%) was also
higher than the 5-1%reportedincidence formultipleprimaries (Moertel, 1966), and
the ratio of deaths from extrathymic neoplasms to all non-myasthenic deaths was
also elevated. All multiple neoplasms and all neoplastic deaths occurred in non-
thymectomypatients.
The 7-5% incidence ofextrathymic neoplasms in the present series is consider-
ably higher than that previously reported in M.G. patients. This increase has
been present in both the thymomatous (8-9%) and the non-thymomatous (7-3%) M.G. patients. The period of highest risk was the one after the onset of M.G.
and before thymectomy (observed neoplasms 64, expected 28).
In theperiodpreceding the onset ofM.G. the low incidence ofneoplasms might
be partly attributable to the omission of persons who developed cancer and died,
who, had they lived, might have developed M.G. This weakness, however, also
exists in any age specific study ofthe incidence of cancer, in that patients who die
from any cause before reaching the age group under study are excluded. In the
M.G. non-thymectomy period a similar problem exists: (a) since M.G. has a high mortality, particular in the first three years of the disease, (Papatestas et al.,
1971; Simpson, 1958) the non-survivors who might have developed cancer are
excluded from the study; (b) more than one-half of the 1243 patients were first
seen at Mount Sinai Hospital after the fifth year from the onset of the disease,642 A. E. PAPATESTAS, K. E. OSSERMAN AND A. E. KARK
therefore patients who had cancer and died in the first five years of the disease
are also excluded from this sample. For these reasons underestimation of the
cancer incidence in the M.G. non-thymectomyperiod is asprobable as in theperiod
before the onset ofM.G.
Because of these limitations and for the reasons described below, we have
studied the incidence of neoplasms in two control groups. The herniorrhaphy
group was included to evaluate whether the annual incidence of cancer in our
hospital population undergoing a complete workup on admission and under close
observation for a year infollow-up clinic, issignificantlyhigher than thatexpected
in a sex and age matched group of the general population. The differences and
the peculiarities in cancer incidence of a hospital population compared with the
general population are well known (Lilienfeld et al., 1967). The incidence of
cancer in theherniorrhaphy group in the year ofadmission wasonlyslightlyhigher
than that expected, while a three-fold increase in cancer incidence in the M.G.
population for the year of the onset of the disease was observed. Furthermore,
in the hernia group there was no difference in the incidence of cancer in the pre-
and post-herniorrhaphy periods.
The M.G. and the herniapatients are notstrictlycomparablepopulations, some
ofthe formerbeing referred to thehospital from out of state or overseas, while the
latter represent a cross section of the population of New York City. Yet the
comparison shows that the sharp increase of cancer coinciding with the onset of
M.G. probably cannot be attributed only to the close follow-up of a hospital
population.
The second control group was chosen to evaluate whether the M.G. pattern of
cancer incidence (Fig. 3) is present in other chronic diseases in which autoimmune
mechanisms are implicated. A pattern similar to that observed in myasthenic
patients was found in that group, i.e. increase in cancer incidence coinciding with
the onset of the disease. However, the increase over the expected incidence for
theperiodfollowingthediagnosisofregionalenteritis wasonlyone-halfthe observed
increase in the M.G. non-thymectomy period. This study is still in progress and
will be reported separately in detail.
It would seem, therefore, that the increase of cancer incidence in the M.G.
non-thymectomy period (Fig. 3) is not attributable to the bias of a retrospective
study, nor to the variations and peculiarities inherent in a study of a hospital
population, but is rather a characteristic ofthe disease itself.
The cancer incidence in the post-thymectomy period showed a marked decline
after the secondpost-operative year. Because ofthe fourneoplasms that occurred
during the first two post-operative years and the small number of person-years
of observation, the risk in the first five post-operative years remained elevated,
while the annual incidence ofneoplasms in the secondfive-yearspost-thymectomy
period fell to theexpected levels ofthegeneralpopulation.
In athymectomy series with alongerfollow-up (average 12 years) reportedby
Doll and Kinlen (1970) the cancer incidence was within the expected general
population levels.
Thefindings of an increased incidenceduring the M.G.non-thymectomyperiod,
together with the observed decrease following thymectomy (Fig. 4), suggests that
the abnormalthymusplays anoneogenic role. Other evidence ofth'ymic involve-
ment in human oncogenesis has been provided by (1) the increased incidence of
reticuloendothelial malignancies in patients with poorly developed or involutedTHYMUS AND ONCOGENESIS 643
thymusglands(primaryimmunologicaldeficienevsvnd-rome: AtaxiaTelangiectasia
of Louis-Bar and the non-sex linked immunoglobulin deficiencies) (Alexander
andGood, 1970); (2)thefrequent occurrenceofextrathymicneoplasms,particularly
of the reticuloendothelial system in patients with autoimmune diseases: rheuma-
toid arthritis (Blumenthal and Berns, 1966; Goldenberg et al., 1969), Sjorgen's
syndrome (Talal and Bunin, 1966), autoimmune anemias (Pirofsky, 1968) and
lupus erythematosus (Miller, 1967). Thymic pathology is a common finding in
these diseases (Miller, 1965) either in the form ofthymichyperplasia withgerminal
center formation and/or epithelial, lymphoepithelial or spindle cell thymomas.
The coexistence ofimmunological deficiencies, autoimmune diseases and neo-
plasia in patients withthymicpathology has led to the suggestionby Miller (1967)
that persistent thymic abnormalities might be associated with diminished resis-
tance to some types ofneoplasia. Thomas (1959) postulated that the function of
cellular immunity is the recognition and rejection of mutant cells as foreign, and
the thymic control mechanism against neoplasia was termed immunosurveillance
by Burnet (1967). In Good's view the surveillance system permits cells whieb are
prone to develop malignancy to function to the advantage rather than disad-
vantage of the host (Good and Finstad, 1968). The suggestion has been made
that this immunosurveillant mechanism is mediated by the small lymphocytes
of thymic origin which are capable of expressing immune responses (Burnet,
1967). The increased frequency of tumors is a recognized hazard of impaired
immunosurveillance (Lawrence, 1970), andthe increase of cancer inelderlypatients
may be attributed to a decreased activity of the thymic immunosurveillance
(Walford, 1969).
The clonal theories ofautoimmunity (Burnet, 1959, 1965; Burch and Burwell,
1965) have attributed autoimmune manifestations to the proliferation of mutant
self-reacting clones ofimmunocompetent lymphocytes that escape the recognition
mechanism ofthymic immunosurveillance, thus proliferating and reacting against
target organs of the host.
Clinical evidence supporting these theories has been provided by the observa-
tions that thymectomy in myasthenia gravis results in stable and permanent
remissions, and that thedelay in the onset ofthese remissions isdirectly related to
theactivityofthethymicgernimalcenters(Papatestasetal.,1971). Thisobserva-
tion, originally made on 64 M.G. patients, has been confirmed in a larger series
(Perlo et al., in press). Since thymic germinal centers are viewed as possible
centers of proliferation of
" forbidden
" clones (Burnet and Holmes, 1966), the
effects ofthymectomy in M.G. could be attributed to the elimination of the sites
ofproliferation of these clones (Papatestas et al., 1971).
Thymectomy in experimental animals is not always followed by an increased
incidence of neoplasia; the reduced occurrence of neoplasms such as mammary
tumors (Allison and Taylor, 1967; Yunis et al., 1969), lymphomas and lymphoid leukemia (Miller, 1961) following experimental thymectomy suggest that the
thymus plays an oneogenic role, in addition to its immunosurveillant one.
It is possible that both these roles are mediated through the small immuno-
competentlymphocytes ofthymicorigin; theallogeneic behaviour ofthe abnormal
self-reacting clones ofthymiclymphocytes might well have an oncogenic potential
sinceallogeneiclymphocytes have been showntopromote chromosomalaberrations
(Fialkow, 1967) and to induce neoplasia in experimental animals (Schwa'rtz and
Beldotti, 1965; Lancet, 1969). Therefore, the increased incidence of neoplasia644 A. E. PAPATESTAS, K. E. OSSERMAN AND A. E. KARK
in autoimmune disease could be linked to the allogeneic behaviour of the self-
reacting clones.
Thereportedfrequent occurrence ofneoplasms intarget organs ofautoimmune
disorders-thymomas in myasthenia gravis, colonic carcinomas in 'ulcerative
colitis and thyroid carcinomas in thyroiditis (Blumenthal and Berns, 1966)-is
consistent with anoneogenic role for the abnormal clones.
In the light of these observations further study of the thymic role in auto-
immunity and human oncogenesis is indicated.
The authors are indebted to R. S. Osserman, B.S., for her invaluable help and
enthusiastic cooperation in reviewing the patients' records. In particular, our
thanks are due to Professor Kurt W. Deuschle, Chairman of the Department of
Community Medicine of the Mount Sinai School of Medicine, for advice on tho
Epidemiological studies.
This work wassupported in partby the Rousso and Fins Foundations.
REFERENCES
ALEXANDER, J. W. AND GoOD, R. A.-(1970) 'Immunobiology for Surgeons'.
Philadelphia (Saunders).
AmISON . A. C. AND TAYLOR, R. A.-(I967) CancerRes.,27, 703.
ALPERT, L. I., PAPATESTAS, A. E., KARK, A - E., OSSERMAN, R. S. AND OSSERMAN,
K. E.-(1971) Archs Path., 91, 55.
ANDERSON, R. J., CHTJRCHILL-DAVIDSON, H. C.ANDRiCHARDSON, A. T.-(1953) Lancet,
ii) 1291.
BLUMENTHAL, H. T.ANDBERNS, A. W.-(1966) Gerontological Res., 1, 289.
BURNET, F. M.-(1965) Br. med. J., i, 338.-(1959) 'The Clonal Selection Theory of
Acquired Immunity'. London (Cambridge University Press).-(1967) Lancet, i,
1171.
BURNET, F.M. ANDHOLMES, M. C.-(1966) J. Path. Bact., 88, 229.
BURCH, P. R. J.ANDBU]EtW]FLL,R. G.-(1965) Q. Rev. Biol., 40, 252.
CANCERREGISTRY OF CONNECTICUT-(1963) Connecticut State Department of Health,
Hartford, Connecticut.
COHEN, S. M. AND WAXMAN, S.-(1967) Archs intern. Med., 120, 717.
DoLL,R. ANDKrNLEN, L.-(1970) Br. med. J., iv, 420.
FERGUSON, F. R.-(1962) Proc. R. Soc. Med., 55, 49.
FiALKOW, P. J.-(1967) Science, N.Y., 155, 1676.
GOLDENBERG, G. J., PARASKEVAS, F. AND ISRAELS, L. G.-(1969) Arthritis Rheum.,
12, 569.
GoOD, R. A.ANDFINSTAD, J.-(1968) Trans. Am. clin. clim. Ass., 79, 60.
KEYNES, G.-(1969) 'The History of Myasthenia Gravis'. In 'Myasthenia Gravis',
edited by R. Greene. Philadelphia (Lippincott).
LAMBERT, E. H. ANDRoOKE, E. D.-(1965) 'Myasthenic State and Lung Cancer'.
In 'The Remote Effects of Cancer on the Nervous Systems Contemporary Neurology Symposia', edited by Lord Brain and F H. Norris. New York
(Grune and Stratton), Vol. 1, p. 67.
Lancet-(1969) i, 194.
LAWRENCE , H. S.-(1970) NewEngl. J. Med., 283, 411.
LiLiENFELD, A. M., PEDERSEN, E. ANDDOED, J. E.-(1967) 'Cancer Epidemiology: Methods ofStudy'. Baltimore (Johns Hopkins Press).
MILLER, D. G.-(I967) Ann. intern. Med., 66, 507.THYMUS AND ONCOGENESIS 645
MILLER, J. F. A. P.-(1961) Adv. Cancer Res., 6, 291.-(1965) 'The Function of the
Thymus in Immunity the Scientific Basis of Surgery', edited by W. T. Irving. London (Churchill), p. 468.-(1967) 'The Thymus in Relation of Neoplasia. Modern Trends in Pathology', edited by T. Crawford. New York (Appleton Century Crafts), Vol. 2, 140.
MOERTEL. G. G.-(1966) 'Multiple Primary Malignant Neoplasms. Their Incidence anA Significance'. New York (Springer-Verlag Inc.). OSSERMAN, K. E.-(1958) 'Myasthenia Gravis'. New York (Grune and Straton). PAPATESTAS, A. E., ALPERT, L. I., OSSERMAN, K. E., OSSERMAN, R. S. AND KARK, A. E.
-(1971) Am. J. med., 50, 465.
PERLO, V., ARNASON, B., POSKANZER, D. M., CASTLEMAN, D., SCHWAB, R. S., OSSERMAN,
K. E., PAPATESTAS, A. E., ALPERT, L. I. AND KARK, A. E.-(1971) Ann. N.Y.
Acad. Sci., 183, 308.
PMOFSKY, B.-(1968) Ann. intern. Med., 68, 109.
SCHWARTZ, R. S. AND BELDOTTI, L.-(1965) Science, N.Y., 149, 1511.
SIMPSON, J. A.-(1958) Brain, 81, 112.
SOUDJIAN, J. B., SILVERSTEIN, M. N. AND TITUS, J. L.-(1968) Cancer, N.Y., 22, 1221.
TALAL, N. AND BuxiN, J. J.-(1966) Am. J. Med., 36, 529.
THOMAS, L.-(1959) Discussion of Medawar P.B.: 'Reactions to homologous tissue
antigens in relation to hypersensitivity, cellular and humoral aspects of the
hypersensitive states', edited by H. S. Lawrence. New York (Harper Medical
Division, Harper and Row) p. 529.
WALFORD, R. L.-(1969) 'Etiology and Pathogenesis ofAging, Consideration from an
Immune Standpoint, the Immunologic Theory ofAging'. Baltimore (Williams
and Wilkins), p. 137.
WOLF, S. M., ROWLAND, L. P. AND SCIROTLAND, D. L.-(1966) Ann. N.Y. Acad. Sci., 135, 517.
YUNIS, E. J., MARTINEZ, C., SMITH, J., STUTMAN, 0. AND GoOD, R. A.-(1969) Cancer
Res., 29, 174.